盘龙药业
(002864)
| 流通市值：20.80亿 | | | 总市值：29.88亿 |
| 流通股本：7398.46万 | | | 总股本：1.06亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 250,212,341.68 | 973,864,163.02 | 716,922,919.85 | 455,356,633.75 |
| 营业收入 | 250,212,341.68 | 973,864,163.02 | 716,922,919.85 | 455,356,633.75 |
| 二、营业总成本 | 213,738,632.71 | 843,758,147.88 | 621,571,912.66 | 391,905,428.8 |
| 营业成本 | 115,323,173.18 | 381,516,125.9 | 274,057,046.13 | 171,037,480.65 |
| 税金及附加 | 2,810,045.06 | 11,168,819.68 | 8,354,269.09 | 5,569,712.94 |
| 销售费用 | 84,211,349.04 | 367,022,980.07 | 285,227,399.41 | 182,179,446.22 |
| 管理费用 | 13,407,202.35 | 69,834,307.62 | 48,012,252.21 | 31,294,733.1 |
| 研发费用 | 4,642,275.19 | 37,537,758.87 | 23,846,304.9 | 14,256,105.42 |
| 财务费用 | -6,655,412.11 | -23,321,844.26 | -17,925,359.08 | -12,432,049.53 |
| 其中:利息费用 | 723,785.66 | 1,561,122.08 | 2,639,361.19 | 1,710,512.26 |
| 其中:利息收入 | 7,393,346.51 | 24,947,082.05 | 20,617,912.28 | 14,187,267.19 |
| 加:投资收益 | -53,134.09 | 630,894.09 | -171,589.02 | -117,289.76 |
| 资产处置收益 | -315.97 | -14,127.67 | -4,470.58 | -128.18 |
| 资产减值损失(新) | 55,058.78 | -225,002.29 | -7,083.23 | -200,203.8 |
| 信用减值损失(新) | -2,360,867.47 | -2,220,668.36 | -3,870,745 | -5,339,050.16 |
| 其他收益 | 2,110,821.88 | 10,089,903.59 | 6,739,055.06 | 5,033,588.78 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 36,225,272.1 | 138,367,014.5 | 98,036,174.42 | 62,828,121.83 |
| 加:营业外收入 | 1,310.4 | 193,542.49 | 5,138,360.49 | 5,110,646.63 |
| 减:营业外支出 | 7,398.14 | 1,608,733.37 | 1,598,463.71 | 270,305.04 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 36,219,184.36 | 136,951,823.62 | 101,576,071.2 | 67,668,463.42 |
| 减:所得税费用 | 5,053,342.39 | 17,027,133.71 | 12,293,422.61 | 8,233,016.01 |
| 六、净利润 | 31,165,841.97 | 119,924,689.91 | 89,282,648.59 | 59,435,447.41 |
| 持续经营净利润 | 31,165,841.97 | 119,924,689.91 | 89,282,648.59 | 59,435,447.41 |
| 归属于母公司股东的净利润 | 31,249,274.14 | 120,271,592.81 | 89,571,690.67 | 59,653,263.68 |
| 少数股东损益 | -83,432.17 | -346,902.9 | -289,042.08 | -217,816.27 |
| (一)基本每股收益 | 0.3 | 1.15 | 0.85 | 0.57 |
| (二)稀释每股收益 | 0.3 | 1.15 | 0.85 | 0.57 |
| 九、综合收益总额 | 31,165,841.97 | 119,924,689.91 | 89,282,648.59 | 59,435,447.41 |
| 归属于母公司股东的综合收益总额 | 31,249,274.14 | 120,271,592.81 | 89,571,690.67 | 59,653,263.68 |
| 归属于少数股东的综合收益总额 | -83,432.17 | -346,902.9 | -289,042.08 | -217,816.27 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-28 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |